Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Meghan Elizabeth Sise, M.D.


The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R03DK128533 (SISE, MEGHAN E.) Feb 4, 2021 - Jan 31, 2023
    Effect of Covid-19 on chronic kidney disease progression
    Role: Principal Investigator
  2. K23DK117014 (SISE, MEGHAN E.) Jul 1, 2018 - Apr 30, 2023
    Effect of Hepatitis C Virus Eradication on Chronic Kidney Disease Progression
    Role: Principal Investigator

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Sise ME, McQuaid T, Martin P. Sofosbuvir-based hepatitis C therapies in patients with chronic and end-stage kidney disease. Nephrol Dial Transplant. 2022 Nov 23; 37(12):2327-2334. PMID: 33848334.
    Citations:    Fields:    
  2. Murakami N, Hayden R, Hills T, Al-Samkari H, Casey J, Del Sorbo L, Lawler PR, Sise ME, Leaf DE. Therapeutic advances in COVID-19. Nat Rev Nephrol. 2022 Oct 17. PMID: 36253508; PMCID: PMC9574806.
    Citations:    Fields:    
  3. Gupta S, Garcia-Carro C, Prosek JM, Glezerman I, Herrmann SM, Garcia P, Abudayyeh A, Lumlertgul N, Malik AB, Loew S, Beckerman P, Renaghan AD, Carlos CA, Rashidi A, Mithani Z, Deshpande P, Rangarajan S, Shah CV, Seigneux S, Campedel L, Kitchlu A, Shin DS, Coppock G, Ortiz-Melo DI, Sprangers B, Aggarwal V, Benesova K, Wanchoo R, Murakami N, Cortazar FB, Reynolds KL, Sise ME, Soler MJ, Leaf DE. Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI. J Immunother Cancer. 2022 09; 10(9). PMID: 36137651; PMCID: PMC9511654.
    Citations:    Fields:    Translation:Humans
  4. Gupta S, Strohbehn IA, Wang Q, Hanna PE, Seethapathy R, Prosek JM, Herrmann SM, Abudayyeh A, Malik AB, Loew S, Carlos CA, Chang WT, Beckerman P, Mithani Z, Shah CV, Renaghan AD, de Seigneux S, Campedel L, Kitchlu A, Shin DS, Coppock G, Lumlertgul N, Garcia P, Ortiz-Melo DI, Rashidi A, Sprangers B, Aggarwal V, Benesova K, Jhaveri KD, Cortazar FB, Weins A, Zuo Y, Mooradian MJ, Reynolds KL, Leaf DE, Sise ME. Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer. Kidney Int. 2022 10; 102(4):930-935. PMID: 35964800; PMCID: PMC9523226.
    Citations:    Fields:    Translation:Humans
  5. Hanna P, Strohbehn I, Moreno D, Harden D, Seethapathy H, Gupta S, Lee M, Ouyang T, Frigault M, Sise ME. Comparison of short- and long-term adverse kidney outcomes after chimeric antigen receptor T cell therapy and autologous hematopoietic stem cell transplant for diffuse large B cell lymphoma. Bone Marrow Transplant. 2022 10; 57(10):1623-1625. PMID: 35922564.
    Citations:    Fields:    Translation:Humans
  6. Wang Q, Moledina DG, Sise ME. Immune checkpoint inhibitors and kidney disease. Curr Opin Nephrol Hypertens. 2022 09 01; 31(5):449-455. PMID: 35894279.
    Citations:    Fields:    Translation:Humans
  7. Hanna P, Strohbehn I, Wang Q, Frigault M, Sise ME. Acute kidney injury caused by haplostorm after allogenic hematopoietic stem cell transplant. Bone Marrow Transplant. 2022 09; 57(9):1442-1444. PMID: 35661834.
    Citations:    Fields:    
  8. Tiu BC, Zubiri L, Iheke J, Pahalyants V, Theodosakis N, Ugwu-Dike P, Seo J, Tang K, Sise ME, Sullivan R, Naidoo J, Mooradian MJ, Semenov YR, Reynolds KL. Real-world incidence and impact of pneumonitis in patients with lung cancer treated with immune checkpoint inhibitors: a multi-institutional cohort study. J Immunother Cancer. 2022 06; 10(6). PMID: 35705313; PMCID: PMC9204442.
    Citations:    Fields:    Translation:Humans
  9. Sulkowski M, Telep LE, Colombo M, Durand F, Reddy KR, Lawitz E, Bourlière M, Cheinquer N, Scherbakovsky S, Ni L, Force L, Ramroth H, Gaggar A, Chokkalingam AP, Sise ME. Sofosbuvir and risk of estimated glomerular filtration rate decline or end-stage renal disease in patients with renal impairment. Aliment Pharmacol Ther. 2022 05; 55(9):1169-1178. PMID: 35235245; PMCID: PMC9313579.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  10. Gudsoorkar P, Jhaveri KD, Sise ME. Onconephrology: The Growth of Cancer-Kidney Connection, Part 2. Adv Chronic Kidney Dis. 2022 03; 29(2):83-85. PMID: 35817529.
    Citations:    Fields:    Translation:Humans
  11. Seethapathy H, Lee MD, Strohbehn IA, Efe O, Rusibamayila N, Chute DF, Colvin RB, Rosales IA, Fadden RM, Reynolds KL, Sullivan RJ, Kaufman HL, Jhaveri KD, Sise ME. Clinical features of acute kidney injury in patients receiving dabrafenib and trametinib. Nephrol Dial Transplant. 2022 02 25; 37(3):507-514. PMID: 33355659; PMCID: PMC8875461.
    Citations: 1     Fields:    Translation:Humans
  12. Chewcharat A, Phipps EA, Bhatia K, Kalim S, Allegretti AS, Sise ME, Paunescu TG, Seethapathy R, Nigwekar SU. The association between olfactory and gustatory dysfunction and chronic kidney disease. BMC Nephrol. 2022 01 18; 23(1):36. PMID: 35042465; PMCID: PMC8767746.
    Citations:    Fields:    Translation:Humans
  13. Strohbehn IA, Street S, Chute D, Seethapathy H, Lee M, Seethapathy R, Drobni ZD, Rahma O, Neilan TG, Zubiri L, Reynolds K, Sise ME. Immune checkpoint inhibitor-induced thyroiditis is a risk factor for acute and chronic kidney dysfunction. Nephrol Dial Transplant. 2021 12 31; 37(1):187-189. PMID: 34383953; PMCID: PMC8719582.
    Citations: 1     Fields:    Translation:Humans
  14. Seethapathy R, Zhao S, Long JD, Strohbehn IA, Sise ME. A Propensity Score-Matched Observational Study of Remdesivir in Patients with COVID-19 and Severe Kidney Disease. Kidney360. 2022 02 24; 3(2):269-278. PMID: 35373125; PMCID: PMC8967642.
    Citations: 2     Translation:HumansCells
  15. Seethapathy H, Rusibamayila N, Chute DF, Lee M, Strohbehn I, Zubiri L, Faje AT, Reynolds KL, Jhaveri KD, Sise ME. Hyponatremia and other electrolyte abnormalities in patients receiving immune checkpoint inhibitors. Nephrol Dial Transplant. 2021 12 02; 36(12):2241-2247. PMID: 33374011; PMCID: PMC8643613.
    Citations: 7     Fields:    Translation:Humans
  16. Sise ME, Goldberg DS, Schaubel DE, Fontana RJ, Kort JJ, Alloway RR, Durand CM, Blumberg EA, Woodle ES, Sherman KE, Brown RS, Friedewald JJ, Desai NM, Sultan ST, Levitsky J, Lee MD, Strohbehn IA, Landis JR, Fernando M, Gustafson JL, Chung RT, Reese PP. One-Year Outcomes of the Multi-Center StudY to Transplant Hepatitis C-InfeCted kidneys (MYTHIC) Trial. Kidney Int Rep. 2022 Feb; 7(2):241-250. PMID: 35155863; PMCID: PMC8820987.
    Citations: 1     
  17. Yuan Q, Cui H, Leya GA, Hong S, Roth EM, Sise ME, Bethea ED, Yeh H, Williams WW, Elias N. Temporal trends and impact of willingness to accept organs from donors with hepatitis C virus. Transpl Int. 2021 12; 34(12):2562-2569. PMID: 34726801.
    Citations:    Fields:    Translation:HumansCells
  18. Long JD, Strohbehn I, Sawtell R, Bhattacharyya R, Sise ME. COVID-19 Survival and its impact on chronic kidney disease. Transl Res. 2022 03; 241:70-82. PMID: 34774843; PMCID: PMC8579714.
    Citations: 2     Fields:    Translation:HumansCells
  19. Yuan Q, Haque O, Hong S, Ortiz A, Bethea ED, Sise ME, Markmann JF, Elias N. Influence of donor and recipient hepatitis B virus infection on long-term outcomes after kidney transplantation. Clin Transplant. 2021 12; 35(12):e14466. PMID: 34545965.
    Citations:    Fields:    Translation:HumansCells
  20. Seethapathy H, Herrmann SM, Sise ME. Immune Checkpoint Inhibitors and Kidney Toxicity: Advances in Diagnosis and Management. Kidney Med. 2021 Nov-Dec; 3(6):1074-1081. PMID: 34939017; PMCID: PMC8664750.
  21. Molnar MZ, Potluri VS, Schaubel DE, Sise ME, Concepcion BP, Forbes RC, Blumberg E, Bloom RD, Shaffer D, Chung RT, Strohbehn IA, Elias N, Azhar A, Shah M, Sawinski D, Binari LA, Talwar M, Balaraman V, Bhalla A, Eason JD, Besharatian B, Trofe-Clark J, Goldberg DS, Reese PP. Association of donor hepatitis C virus infection status and risk of BK polyomavirus viremia after kidney transplantation. Am J Transplant. 2022 02; 22(2):599-609. PMID: 34613666; PMCID: PMC8968853.
    Citations: 3     Fields:    Translation:HumansCells
  22. Ferreira CA, Heidari P, Ataeinia B, Sinevici N, Sise ME, Colvin RB, Wehrenberg-Klee E, Mahmood U. Non-invasive Detection of Immunotherapy-Induced Adverse Events. Clin Cancer Res. 2021 10 01; 27(19):5353-5364. PMID: 34253581; PMCID: PMC8752648.
    Citations: 1     Fields:    Translation:HumansAnimals
  23. Gupta S, Short SAP, Sise ME, Prosek JM, Madhavan SM, Soler MJ, Ostermann M, Herrmann SM, Abudayyeh A, Anand S, Glezerman I, Motwani SS, Murakami N, Wanchoo R, Ortiz-Melo DI, Rashidi A, Sprangers B, Aggarwal V, Malik AB, Loew S, Carlos CA, Chang WT, Beckerman P, Mithani Z, Shah CV, Renaghan AD, Seigneux S, Campedel L, Kitchlu A, Shin DS, Rangarajan S, Deshpande P, Coppock G, Eijgelsheim M, Seethapathy H, Lee MD, Strohbehn IA, Owen DH, Husain M, Garcia-Carro C, Bermejo S, Lumlertgul N, Seylanova N, Flanders L, Isik B, Mamlouk O, Lin JS, Garcia P, Kaghazchi A, Khanin Y, Kansal SK, Wauters E, Chandra S, Schmidt-Ott KM, Hsu RK, Tio MC, Sarvode Mothi S, Singh H, Schrag D, Jhaveri KD, Reynolds KL, Cortazar FB, Leaf DE. Acute kidney injury in patients treated with immune checkpoint inhibitors. J Immunother Cancer. 2021 10; 9(10). PMID: 34625513; PMCID: PMC8496384.
    Citations: 9     Fields:    Translation:Humans
  24. Portales-Castillo IA, Aksu C, Zhao S, Strohbehn I, Sise M, Yu EW, Nigwekar SU. Prescription Patterns of Osteoporosis Medications in Patients With Advanced CKD: A Retrospective Cohort Study. Kidney Med. 2021 Nov-Dec; 3(6):1112-1115. PMID: 34939026.
  25. Seethapathy H, Street S, Strohbehn I, Lee M, Zhao SH, Rusibamayila N, Chute DF, Gao X, Michaelson MD, Rahma OE, Choueiri TK, McGregor B, Sonpavde G, Salabao C, Kaymakcalan MD, Wei X, Gupta S, Motwani S, Leaf DE, Reynolds KL, Sise ME. Immune-related adverse events and kidney function decline in patients with genitourinary cancers treated with immune checkpoint inhibitors. Eur J Cancer. 2021 11; 157:50-58. PMID: 34482189.
    Citations: 1     Fields:    Translation:Humans
  26. Zubiri L, Molina GE, Mooradian MJ, Cohen J, Durbin SM, Petrillo L, Boland GM, Juric D, Dougan M, Thomas MF, Faje AT, Rengarajan M, Guidon AC, Chen ST, Okin D, Medoff BD, Nasrallah M, Kohler MJ, Schoenfeld SR, Karp-Leaf RS, Sise ME, Neilan TG, Zlotoff DA, Farmer JR, Bardia A, Sullivan RJ, Blum SM, Semenov YR, Villani AC, Reynolds KL. Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer. J Immunother Cancer. 2021 09; 9(9). PMID: 34544895; PMCID: PMC8454442.
    Citations: 1     Fields:    Translation:Humans
  27. Chuang WL, Hu TH, Buggisch P, Moreno C, Su WW, Biancone L, Camargo M, Hyland R, Lu S, Kirby BJ, Dvory-Sobol H, Osinusi A, Gaggar A, Peng CY, Liu CH, Sise ME, Mangia A. Ledipasvir/Sofosbuvir for 8, 12, or 24 Weeks in Hepatitis C Patients Undergoing Dialysis for End-Stage Renal Disease. Am J Gastroenterol. 2021 09 01; 116(9):1924-1928. PMID: 34465694.
    Citations: 2     Fields:    Translation:Humans
  28. Gudsoorkar P, Sise ME, Jhaveri KD. Onconephrology: The Growth of Cancer-Kidney Connection. Adv Chronic Kidney Dis. 2021 09; 28(5):391-393. PMID: 35190105.
    Citations:    Fields:    Translation:Humans
  29. Lee M, Wang Q, Wanchoo R, Eswarappa M, Deshpande P, Sise ME. Chronic Kidney Disease in Cancer Survivors. Adv Chronic Kidney Dis. 2021 09; 28(5):469-476.e1. PMID: 35190113.
    Citations:    Fields:    Translation:Humans
  30. Nguyen T, Sise ME, Delgado C, Williams W, Reese P, Goldberg D. Race, Education, and Gender Disparities in Transplantation of Kidneys From Hepatitis C Viremic Donors. Transplantation. 2021 08 01; 105(8):1850-1857. PMID: 33141804; PMCID: PMC8842824.
    Citations: 2     Fields:    Translation:Humans
  31. Strohbehn IA, Zhao S, Seethapathy H, Lee M, Rusibamayila N, Allegretti AS, Parada XV, Sise ME. Acute Kidney Injury Incidence, Recovery, and Long-term Kidney Outcomes Among Hospitalized Patients With COVID-19 and Influenza. Kidney Int Rep. 2021 Oct; 6(10):2565-2574. PMID: 34307971; PMCID: PMC8280679.
    Citations: 6     
  32. Reynolds KL, Arora S, Elayavilli RK, Louv WC, Schaller TH, Khandelwal A, Rothenberg M, Khozin S, Guidon AC, Dougan M, Zubiri L, Petrillo L, Sise ME, Villani AC, Johnson DB, Rahma O, Sharon E. Immune-related adverse events associated with immune checkpoint inhibitors: a call to action for collecting and sharing clinical trial and real-world data. J Immunother Cancer. 2021 07; 9(7). PMID: 34215691.
    Citations: 5     Fields:    Translation:Humans
  33. Chute DF, Zhao S, Strohbehn IA, Rusibamayila N, Seethapathy H, Lee M, Zubiri L, Gupta S, Leaf DE, Rahma O, Drobni ZD, Neilan TG, Reynolds KL, Sise ME. Incidence and Predictors of CKD and Estimated GFR Decline in Patients Receiving Immune Checkpoint Inhibitors. Am J Kidney Dis. 2022 01; 79(1):134-137. PMID: 34174363; PMCID: PMC8855486.
    Citations: 3     Fields:    Translation:Humans
  34. Drobni ZD, Murphy SP, Alvi RM, Lee C, Gong J, Mosarla RC, Rambarat PK, Hartmann SB, Gilman HK, Zubiri L, Raghu VK, Sullivan RJ, Zafar A, Zlotoff DA, Sise ME, Guidon AC, Reynolds KL, Dougan M, Neilan TG. Association between incidental statin use and skeletal myopathies in patients treated with immune checkpoint inhibitors. Immunother Adv. 2021 Jan; 1(1):ltab014. PMID: 34541581; PMCID: PMC8444991.
    Citations: 2     
  35. Gong J, Drobni ZD, Zafar A, Quinaglia T, Hartmann S, Gilman HK, Raghu VK, Gongora C, Sise ME, Alvi RM, Zubiri L, Nohria A, Sullivan R, Reynolds KL, Zlotoff D, Neilan TG. Pericardial disease in patients treated with immune checkpoint inhibitors. J Immunother Cancer. 2021 06; 9(6). PMID: 34145031.
    Citations: 2     Fields:    Translation:Humans
  36. Strohbehn IA, Seethapathy R, Lee M, Sise ME. Curative Therapies for Hepatitis C Virus Infection in Patients with Kidney Disease. Kidney360. 2021 08 26; 2(8):1316-1325. PMID: 35369667; PMCID: PMC8676392.
    Citations:    Translation:HumansCells
  37. Street S, Chute D, Strohbehn I, Zhao S, Rengarajan M, Faje A, Seethapathy H, Lee M, Seethapathy R, Drobni Z, Rahma O, Neilan TG, Sullivan RJ, Villani AC, Zubiri L, Mooradian MJ, Reynolds KL, Sise ME. The positive effect of immune checkpoint inhibitor-induced thyroiditis on overall survival accounting for immortal time bias: a retrospective cohort study of 6596 patients. Ann Oncol. 2021 08; 32(8):1050-1051. PMID: 34020034; PMCID: PMC8814352.
    Citations: 8     Fields:    Translation:Humans
  38. Lee MD, Seethapathy H, Strohbehn IA, Zhao SH, Boland GM, Fadden R, Sullivan R, Reynolds KL, Sise ME. Rapid corticosteroid taper versus standard of care for immune checkpoint inhibitor induced nephritis: a single-center retrospective cohort study. J Immunother Cancer. 2021 04; 9(4). PMID: 33849926; PMCID: PMC8051410.
    Citations: 3     Fields:    Translation:Humans
  39. Molina GE, Zubiri L, Cohen JV, Durbin SM, Petrillo L, Allen IM, Murciano-Goroff YR, Dougan M, Thomas MF, Faje AT, Rengarajan M, Guidon AC, Chen ST, Okin D, Medoff BD, Nasrallah M, Kohler MJ, Schoenfeld SR, Karp Leaf RS, Sise ME, Neilan TG, Zlotoff DA, Farmer JR, Mooradian MJ, Bardia A, Mai M, Sullivan RJ, Semenov YR, Villani AC, Reynolds KL. Temporal Trends and Outcomes Among Patients Admitted for Immune-Related Adverse Events: A Single-Center Retrospective Cohort Study from 2011 to 2018. Oncologist. 2021 06; 26(6):514-522. PMID: 33655682; PMCID: PMC8176966.
    Citations: 5     Fields:    Translation:Humans
  40. Murakami N, Mulvaney P, Danesh M, Abudayyeh A, Diab A, Abdel-Wahab N, Abdelrahim M, Khairallah P, Shirazian S, Kukla A, Owoyemi IO, Alhamad T, Husami S, Menon M, Santeusanio A, Blosser CD, Zuniga SC, Soler MJ, Moreso F, Mithani Z, Ortiz-Melo D, Jaimes EA, Gutgarts V, Lum E, Danovitch GM, Cardarelli F, Drews RE, Bassil C, Swank JL, Westphal S, Mannon RB, Shirai K, Kitchlu A, Ong S, Machado SM, Mothi SS, Ott PA, Rahma O, Hodi FS, Sise ME, Gupta S, Leaf DE, Devoe CE, Wanchoo R, Nair VV, Schmults CD, Hanna GJ, Sprangers B, Riella LV, Jhaveri KD. A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant. Kidney Int. 2021 07; 100(1):196-205. PMID: 33359528; PMCID: PMC8222056.
    Citations: 17     Fields:    Translation:Humans
  41. Estiverne C, Strohbehn IA, Mithani Z, Hirsch JS, Wanchoo R, Goyal PG, Lee Dryden-Peterson S, Pearson JC, Kubiak DW, Letourneau AR, Bhattacharyya R, Jhaveri KD, Sise ME. Remdesivir in Patients With Estimated GFR <30 ml/min per 1.73 m2 or on Renal Replacement Therapy. Kidney Int Rep. 2021 Mar; 6(3):835-838. PMID: 33263094.
    Citations: 5     
  42. Lee MD, Strohbehn IA, Seethapathy HS, Rusibamayila N, Casey KS, Gupta S, Leaf DE, Frigault MJ, Sise ME. Acute Kidney Injury After the CAR-T Therapy Tisagenlecleucel. Am J Kidney Dis. 2021 06; 77(6):990-992. PMID: 33098925; PMCID: PMC8060348.
    Citations: 4     Fields:    Translation:Humans
  43. Chewcharat A, Chang YT, Sise ME, Bhattacharyya RP, Murray MB, Nigwekar SU. Phase-3 Randomized Controlled Trials on Exclusion of Participants With Kidney Disease in COVID-19. Kidney Int Rep. 2021 Jan; 6(1):196-199. PMID: 33106779.
    Citations: 3     
  44. Ng JH, Bijol V, Sparks MA, Sise ME, Izzedine H, Jhaveri KD. Pathophysiology and Pathology of Acute Kidney Injury in Patients With COVID-19. Adv Chronic Kidney Dis. 2020 09; 27(5):365-376. PMID: 33308501.
    Citations: 37     Fields:    Translation:HumansCells
  45. Gupta S, Coca SG, Chan L, Melamed ML, Brenner SK, Hayek SS, Sutherland A, Puri S, Srivastava A, Leonberg-Yoo A, Shehata AM, Flythe JE, Rashidi A, Schenck EJ, Goyal N, Hedayati SS, Dy R, Bansal A, Athavale A, Nguyen HB, Vijayan A, Charytan DM, Schulze CE, Joo MJ, Friedman AN, Zhang J, Sosa MA, Judd E, Velez JCQ, Mallappallil M, Redfern RE, Bansal AD, Neyra JA, Liu KD, Renaghan AD, Christov M, Molnar MZ, Sharma S, Kamal O, Boateng JO, Short SAP, Admon AJ, Sise ME, Wang W, Parikh CR, Leaf DE. AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19. J Am Soc Nephrol. 2021 01; 32(1):161-176. PMID: 33067383.
    Citations: 80     Fields:    Translation:Humans
  46. Endres P, Rosovsky R, Zhao S, Krinsky S, Percy S, Kamal O, Roberts RJ, Lopez N, Sise ME, Steele DJR, Lundquist AL, Rhee EP, Hibbert KA, Hardin CC, Mc Causland FR, Czarnecki PG, Mutter W, Tolkoff-Rubin N, Allegretti AS. Filter clotting with continuous renal replacement therapy in COVID-19. J Thromb Thrombolysis. 2021 May; 51(4):966-970. PMID: 33026569; PMCID: PMC7539277.
    Citations: 9     Fields:    Translation:HumansCells
  47. Sise ME, Goldberg DS, Kort JJ, Schaubel DE, Alloway RR, Durand CM, Fontana RJ, Brown RS, Friedewald JJ, Prenner S, Landis JR, Fernando M, Phillips CC, Woodle ES, Rike-Shields A, Sherman KE, Elias N, Williams WW, Gustafson JL, Desai NM, Barnaba B, Norman SP, Doshi M, Sultan ST, Aull MJ, Levitsky J, Belshe DS, Chung RT, Reese PP. Multicenter Study to Transplant Hepatitis C-Infected Kidneys (MYTHIC): An Open-Label Study of Combined Glecaprevir and Pibrentasvir to Treat Recipients of Transplanted Kidneys from Deceased Donors with Hepatitis C Virus Infection. J Am Soc Nephrol. 2020 11; 31(11):2678-2687. PMID: 32843477; PMCID: PMC7608971.
    Citations: 17     Fields:    Translation:HumansCellsCTClinical Trials
  48. Seethapathy H, Zhao S, Strohbehn IA, Lee M, Chute DF, Bates H, Molina GE, Zubiri L, Gupta S, Motwani S, Leaf DE, Sullivan RJ, Rahma O, Blumenthal KG, Villani AC, Reynolds KL, Sise ME. Incidence and Clinical Features of Immune-Related Acute Kidney Injury in Patients Receiving Programmed Cell Death Ligand-1 Inhibitors. Kidney Int Rep. 2020 Oct; 5(10):1700-1705. PMID: 33102962; PMCID: PMC7569697.
    Citations: 10     
  49. Johnson DB, Jakubovic BD, Sibaud V, Sise ME. Balancing Cancer Immunotherapy Efficacy and Toxicity. J Allergy Clin Immunol Pract. 2020 10; 8(9):2898-2906. PMID: 32599218.
    Citations: 10     Fields:    Translation:Humans
  50. Adamsick ML, Gandhi RG, Bidell MR, Elshaboury RH, Bhattacharyya RP, Kim AY, Nigwekar S, Rhee EP, Sise ME. Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19. J Am Soc Nephrol. 2020 07; 31(7):1384-1386. PMID: 32513665.
    Citations: 53     Fields:    Translation:HumansPHPublic Health
  51. Sise ME, Strohbehn I, Chute D, Corey KE, Fusco DN, Sabbisetti VS, Waikar SS, Chung RT. Low Complement C4 Predicts Improvement of Kidney Function After Direct-Acting Antiviral Therapy for Hepatitis C Virus. Hepatol Commun. 2020 Aug; 4(8):1206-1217. PMID: 32766479.
    Citations: 1     Fields:    
  52. Strohbehn IA, Lee M, Seethapathy H, Chute D, Rahma O, Guidon A, Neilan TG, Zlotoff DA, Okin D, Rengarajan M, Reynolds K, Sise ME. Safety and Efficacy of Immune Checkpoint Inhibitors in Patients on Dialysis: A Retrospective Case Series. Am J Kidney Dis. 2020 08; 76(2):299-302. PMID: 32417401.
    Citations: 5     Fields:    Translation:Humans
  53. Sise ME, Baggett MV, Shepard JO, Stevens JS, Rhee EP. Case 17-2020: A 68-Year-Old Man with Covid-19 and Acute Kidney Injury. N Engl J Med. 2020 May 28; 382(22):2147-2156. PMID: 32402156; PMCID: PMC7959270.
    Citations: 36     Fields:    Translation:HumansCellsPHPublic Health
  54. Reddy YNV, Reddy KP, Sise ME. HCV-Infected Deceased Donor Kidney Transplantation-Time to Take Up the Offer. Am J Kidney Dis. 2020 06; 75(6):827-829. PMID: 32317120.
    Citations:    Fields:    Translation:Humans
  55. Seethapathy H, Bates H, Chute DF, Strohbehn I, Strohbehn S, Fadden RM, Reynolds KL, Cohen JV, Sullivan RJ, Sise ME. Acute Kidney Injury Following Encorafenib and Binimetinib for Metastatic Melanoma. Kidney Med. 2020 May-Jun; 2(3):373-375. PMID: 32734258.
    Citations: 1     
  56. Strohbehn S, Seethapathy H, Rusibamayila N, Strohbehn I, Lee M, Hobbs G, Keyzner A, Jhaveri KD, Sise ME. Acute kidney injury after ruxolitinib: Common complication, uncommon cause. Am J Hematol. 2020 07; 95(7):E181-E183. PMID: 32239674; PMCID: PMC8018792.
    Citations:    Fields:    Translation:Humans
  57. Roth D, Bloom RD, Molnar MZ, Reese PP, Sawinski D, Sise ME, Terrault NA. KDOQI US Commentary on the 2018 KDIGO Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C. Am J Kidney Dis. 2020 05; 75(5):665-683. PMID: 32279907.
    Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
  58. Bethea E, Arvind A, Gustafson J, Andersson K, Pratt D, Bhan I, Thiim M, Corey K, Bloom P, Markmann J, Yeh H, Elias N, Kimura S, Dageforde LA, Cuenca A, Kawai T, Safa K, Williams W, Gilligan H, Sise M, Fishman J, Kotton C, Kim A, Rogers CC, Shao S, Cote M, Irwin L, Myoung P, Chung RT. Immediate administration of antiviral therapy after transplantation of hepatitis C-infected livers into uninfected recipients: Implications for therapeutic planning. Am J Transplant. 2020 06; 20(6):1619-1628. PMID: 31887236.
    Citations: 9     Fields:    Translation:HumansCells
  59. Gupta S, Seethapathy H, Strohbehn IA, Frigault MJ, O'Donnell EK, Jacobson CA, Motwani SS, Parikh SM, Curhan GC, Reynolds KL, Leaf DE, Sise ME. Acute Kidney Injury and Electrolyte Abnormalities After Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Diffuse Large B-Cell Lymphoma. Am J Kidney Dis. 2020 07; 76(1):63-71. PMID: 31973908.
    Citations: 20     Fields:    Translation:Humans
  60. Sise ME, Strohbehn IA, Chute DF, Gustafson J, Van Deerlin VM, Smith JR, Gentile C, Wojciechowski D, Williams WW, Elias N, Chung RT. Preemptive Treatment With Elbasvir and Grazoprevir for Hepatitis C-Viremic Donor to Uninfected Recipient Kidney Transplantation. Kidney Int Rep. 2020 Apr; 5(4):459-467. PMID: 32280841; PMCID: PMC7136432.
    Citations: 10     
  61. Cortazar FB, Kibbelaar ZA, Glezerman IG, Abudayyeh A, Mamlouk O, Motwani SS, Murakami N, Herrmann SM, Manohar S, Shirali AC, Kitchlu A, Shirazian S, Assal A, Vijayan A, Renaghan AD, Ortiz-Melo DI, Rangarajan S, Malik AB, Hogan JJ, Dinh AR, Shin DS, Marrone KA, Mithani Z, Johnson DB, Hosseini A, Uprety D, Sharma S, Gupta S, Reynolds KL, Sise ME, Leaf DE. Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study. J Am Soc Nephrol. 2020 02; 31(2):435-446. PMID: 31896554; PMCID: PMC7003302.
    Citations: 69     Fields:    Translation:Humans
  62. Lawitz E, Flisiak R, Abunimeh M, Sise ME, Park JY, Kaskas M, Bruchfeld A, Wörns MA, Aglitti A, Zamor PJ, Xue Z, Schnell G, Jalundhwala YJ, Porcalla A, Mensa FJ, Persico M. Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection. Liver Int. 2020 05; 40(5):1032-1041. PMID: 31821716.
    Citations: 13     Fields:    Translation:HumansCTClinical Trials
  63. Qualls D, Seethapathy H, Bates H, Tajmir S, Heidari P, Endres P, Reynolds K, Lawrence D, Sise M. Positron emission tomography as an adjuvant diagnostic test in the evaluation of checkpoint inhibitor-associated acute interstitial nephritis. J Immunother Cancer. 2019 12 21; 7(1):356. PMID: 31864416.
    Citations: 7     Fields:    Translation:Humans
  64. McMahon GM, Amodu A, Sise ME, Mothi SS, Palsson R, Waikar SS. Physician Attitudes on Kidney Biopsies for Research: A Survey Study. Kidney Med. 2020 Jan-Feb; 2(1):82-84. PMID: 32734230.
  65. Zubiri L, Allen IM, Taylor MS, Guidon AC, Chen ST, Schoenfeld SR, Neilan TG, Sise ME, Mooradian MJ, Rubin KM, Leaf RK, Parikh AR, Faje A, Gainor JF, Cohen JV, Fintelmann FJ, Kohler MJ, Dougan M, Reynolds KL. Immune-Related Adverse Events in the Setting of PD-1/L1 Inhibitor Combination Therapy. Oncologist. 2020 03; 25(3):e398-e404. PMID: 32162817; PMCID: PMC7066708.
    Citations: 3     Fields:    Translation:Humans
  66. Zubiri L, Allen IM, Taylor MS, Guidon AC, Chen ST, Schoenfeld SR, Neilan TG, Sise ME, Mooradian MJ, Rubin KM, Leaf RK, Parikh AR, Faje A, Gainor JF, Cohen JV, Fintelmann FJ, Kohler MJ, Dougan M, Reynolds KL. Immune-Related Adverse Events in the Setting of PD-1/L1 Inhibitor Combination Therapy. Oncologist. 2019 Nov 21. PMID: 31754069.
  67. Seethapathy H, Zhao S, Chute DF, Zubiri L, Oppong Y, Strohbehn I, Cortazar FB, Leaf DE, Mooradian MJ, Villani AC, Sullivan RJ, Reynolds K, Sise ME. The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors. Clin J Am Soc Nephrol. 2019 12 06; 14(12):1692-1700. PMID: 31672794.
    Citations: 62     Fields:    Translation:Humans
  68. Potluri VS, Goldberg DS, Mohan S, Bloom RD, Sawinski D, Abt PL, Blumberg EA, Parikh CR, Sharpe J, Reddy KR, Molnar MZ, Sise M, Reese PP. National Trends in Utilization and 1-Year Outcomes with Transplantation of HCV-Viremic Kidneys. J Am Soc Nephrol. 2019 10; 30(10):1939-1951. PMID: 31515244; PMCID: PMC6779360.
    Citations: 24     Fields:    Translation:Humans
  69. Sise ME, Strohbehn IA, Bethea E, Gustafson JL, Chung RT. Balancing the risk and rewards of utilizing organs from hepatitis C viremic donors. Curr Opin Organ Transplant. 2019 06; 24(3):351-357. PMID: 31090648.
    Citations: 1     Fields:    Translation:Humans
  70. Sise ME, Wojciechowski D, Chute DF, Gustafson J, Chung RT, Williams WW, Elias N. Process of selecting and educating HCV-uninfected kidney waiting-list candidates for HCV-infected kidney transplantation. Artif Organs. 2019 Sep; 43(9):913-920. PMID: 31001828.
    Citations: 2     Fields:    Translation:HumansCells
  71. Sise ME, Chute DF, Oppong Y, Davis MI, Long JD, Silva ST, Rusibamayila N, Jean-Francois D, Raji S, Zhao S, Thadhani R, Chung RT. Direct-acting antiviral therapy slows kidney function decline in patients with Hepatitis C virus infection and chronic kidney disease. Kidney Int. 2020 01; 97(1):193-201. PMID: 31337501.
    Citations: 11     Fields:    Translation:HumansCells
  72. Sise ME, Strohbehn IA, Bethea E, Gustafson JL, Chung RT. Balancing the risk and rewards of utilizing organs from hepatitis C viremic donors. Curr Opin Organ Transplant. 2019 Apr 16. PMID: 31008739.
  73. Sise ME, Seethapathy H, Reynolds KL. Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Renal Toxicity: Illustrative Case and Review. Oncologist. 2019 06; 24(6):735-742. PMID: 30902916.
    Citations: 14     Fields:    Translation:Humans
  74. Sise ME. Safety and Efficacy of Paritaprevir/Ritonavir, Ombitasvir, and Dasabuvir for Hepatitis C Virus Infection Across All Levels of Kidney Function. Kidney Int Rep. 2019 Feb; 4(2):191-193. PMID: 30775615; PMCID: PMC6365390.
    Citations: 2     
  75. Henson JB, Sise ME. The association of hepatitis C infection with the onset of CKD and progression into ESRD. Semin Dial. 2019 03; 32(2):108-118. PMID: 30496620; PMCID: PMC6410728.
    Citations: 8     Fields:    Translation:Humans
  76. Bomback AS, Sise ME. A Three-Headed Approach to Kidney Involvement in Rheumatic Diseases. Rheum Dis Clin North Am. 2018 11; 44(4):xiii-xiv. PMID: 30274633.
    Citations:    Fields:    Translation:Humans
  77. Long JD, Rutledge SM, Sise ME. Autoimmune Kidney Diseases Associated with Chronic Viral Infections. Rheum Dis Clin North Am. 2018 11; 44(4):675-698. PMID: 30274630.
    Citations: 2     Fields:    Translation:Humans
  78. Sise ME. Hepatitis C virus infection and the kidney. Nephrol Dial Transplant. 2018 Jul 27. PMID: 30060216; PMCID: PMC6399482.
    Citations:    Fields:    
  79. Rutledge SM, Chung RT, Sise ME. Treatment of hepatitis C virus infection in patients with mixed cryoglobulinemic syndrome and cryoglobulinemic glomerulonephritis. Hemodial Int. 2018 04; 22 Suppl 1:S81-S96. PMID: 29694729.
    Citations: 8     Fields:    Translation:HumansCells
  80. Sise ME, Chute DF, Gustafson JL, Wojciechowski D, Elias N, Chung RT, Williams WW. Transplantation of hepatitis C virus infected kidneys into hepatitis C virus uninfected recipients. Hemodial Int. 2018 04; 22 Suppl 1:S71-S80. PMID: 29694722.
    Citations: 6     Fields:    Translation:Humans
  81. Chute DF, Sise ME. Effect of the Opioid Crisis on the Donor Pool for Kidney Transplantation: An Analysis of National Kidney Deceased Donor Trends from 2010-2016. Am J Nephrol. 2018; 47(2):84-93. PMID: 29439266.
    Citations: 14     Fields:    Translation:Humans
  82. Chute DF, Chung RT, Sise ME. Direct-acting antiviral therapy for hepatitis C virus infection in the kidney transplant recipient. Kidney Int. 2018 03; 93(3):560-567. PMID: 29325996.
    Citations: 18     Fields:    Translation:HumansCells
  83. Parikh A, Rizzo JA, Canetta P, Forster C, Sise M, Maarouf O, Singer E, Elger A, Elitok S, Schmidt-Ott K, Barasch J, Nickolas TL. Correction: Does NGAL reduce costs? A cost analysis of urine NGAL (uNGAL) & serum creatinine (sCr) for acute kidney injury (AKI) diagnosis. PLoS One. 2017; 12(9):e0185772. PMID: 28953968.
    Citations: 3     Fields:    
  84. Davis MI, Chute DF, Chung RT, Sise ME. When and how can nephrologists treat hepatitis C virus infection in dialysis patients? Semin Dial. 2018 01; 31(1):26-36. PMID: 28925068.
    Citations: 3     Fields:    Translation:Humans
  85. Sise ME, Backman E, Ortiz GA, Hundemer GL, Ufere NN, Chute DF, Brancale J, Xu D, Wisocky J, Lin MV, Kim AY, Thadhani R, Chung RT. Effect of Sofosbuvir-Based Hepatitis C Virus Therapy on Kidney Function in Patients with CKD. Clin J Am Soc Nephrol. 2017 Oct 06; 12(10):1615-1623. PMID: 28882857.
    Citations: 19     Fields:    Translation:Humans
  86. Sise ME. Kidney transplant recipients with hepatitis C virus experienced 100% sustained virologic response at 12 weeks when treated with sofosbuvir-ledipasvir. Hepatology. 2017 10; 66(4):1335-1337. PMID: 28650558.
    Citations:    Fields:    Translation:Humans
  87. Hogan JJ, Lim MA, Palmer MB, Bloom RD, Chung RT, Sise ME. Development of proteinuria and focal segmental glomerulosclerosis during direct-acting antiviral therapy for hepatitis C virus infection. Hepatology. 2017 08; 66(2):658-660. PMID: 28211090.
    Citations: 3     Fields:    Translation:Humans
  88. Parikh A, Rizzo JA, Canetta P, Forster C, Sise M, Maarouf O, Singer E, Elger A, Elitok S, Schmidt-Ott K, Barasch J, Nickolas TL. Does NGAL reduce costs? A cost analysis of urine NGAL (uNGAL) & serum creatinine (sCr) for acute kidney injury (AKI) diagnosis. PLoS One. 2017; 12(5):e0178091. PMID: 28542336.
    Citations: 11     Fields:    Translation:Humans
  89. Sise ME, Lo GC, Goldstein RH, Allegretti AS, Masia R. Case 12-2017 - A 34-Year-Old Man with Nephropathy. N Engl J Med. 2017 04 20; 376(16):1575-1585. PMID: 28423292.
    Citations:    Fields:    Translation:Humans
  90. Sise ME, Wisocky J, Rosales IA, Chute D, Holmes JA, Corapi KM, Babitt JL, Tangren JS, Hashemi N, Lundquist AL, Williams WW, Mount DB, Andersson KL, Rennke HG, Smith RN, Colvin R, Thadhani RI, Chung RT. Lupus-like Immune Complex-mediated Glomerulonephritis in Patients with Hepatitis C Virus Infection Treated with Oral, Interferon-free, Direct-acting Antiviral Therapy. Kidney Int Rep. 2016 Sep; 1(3):135-143. PMID: 27990496; PMCID: PMC5155703.
    Citations: 9     
  91. Lin MV, Sise ME, Pavlakis M, Amundsen BM, Chute D, Rutherford AE, Chung RT, Curry MP, Hanifi JM, Gabardi S, Chandraker A, Heher EC, Elias N, Riella LV. Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection. PLoS One. 2016; 11(7):e0158431. PMID: 27415632.
    Citations: 32     Fields:    Translation:Humans
  92. Saxena V, Koraishy FM, Sise ME, Lim JK, Schmidt M, Chung RT, Liapakis A, Nelson DR, Fried MW, Terrault NA. Safety and efficacy of sofosbuvir-containing regimens in hepatitis C-infected patients with impaired renal function. Liver Int. 2016 06; 36(6):807-16. PMID: 26923436; PMCID: PMC6453817.
    Citations: 87     Fields:    Translation:HumansCells
  93. Sise ME, Bloom AK, Wisocky J, Lin MV, Gustafson JL, Lundquist AL, Steele D, Thiim M, Williams WW, Hashemi N, Kim AY, Thadhani R, Chung RT. Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents. Hepatology. 2016 Feb; 63(2):408-17. PMID: 26474537.
    Citations: 75     Fields:    Translation:HumansCTClinical Trials
  94. Hundemer GL, Sise ME, Wisocky J, Ufere N, Friedman LS, Corey KE, Chung RT. Use of sofosbuvir-based direct-acting antiviral therapy for hepatitis C viral infection in patients with severe renal insufficiency. Infect Dis (Lond). 2015; 47(12):924-9. PMID: 26365684.
    Citations: 14     Fields:    Translation:HumansCells
  95. Sise ME, Hirsch JS, Canetta PA, Herlitz L, Mohan S. Nonalbumin proteinuria predominates in biopsy-proven tenofovir nephrotoxicity. AIDS. 2015 May 15; 29(8):941-6. PMID: 25784440.
    Citations: 13     Fields:    Translation:HumansCells
  96. Sise ME, Backman ES, Wenger JB, Wood BR, Sax PE, Chung RT, Thadhani R, Kim AY. Short and long-term effects of telaprevir on kidney function in patients with hepatitis C virus infection: a retrospective cohort study. PLoS One. 2015; 10(4):e0124139. PMID: 25923243.
    Citations: 2     Fields:    Translation:Humans
  97. Connors NJ, Sise ME, Nelson LS, Hoffman RS, Smith SW. Methotrexate toxicity treated with continuous venovenous hemofiltration, leucovorin and glucarpidase. Clin Kidney J. 2014 Dec; 7(6):590-2. PMID: 25859377; PMCID: PMC4389132.
    Citations: 1     
  98. Strazzula L, Nigwekar SU, Steele D, Tsiaras W, Sise M, Bis S, Smith GP, Kroshinsky D. Intralesional sodium thiosulfate for the treatment of calciphylaxis. JAMA Dermatol. 2013 Aug; 149(8):946-9. PMID: 23760631.
    Citations: 25     Fields:    Translation:Humans
  99. Sise ME, Courtwright AM, Channick RN. Pulmonary hypertension in patients with chronic and end-stage kidney disease. Kidney Int. 2013 Oct; 84(4):682-92. PMID: 23739239.
    Citations: 40     Fields:    Translation:Humans
  100. Sise ME, Parravicini E, Barasch J. Urinary neutrophil gelatinase associated lipocalin identifies neonates with high probability of sepsis. Pediatrics. 2012 Oct; 130(4):e1053-4; author reply e1055-7. PMID: 23035240.
    Citations: 1     Fields:    Translation:Humans
  101. Nickolas TL, Forster CS, Sise ME, Barasch N, Solá-Del Valle D, Viltard M, Buchen C, Kupferman S, Carnevali ML, Bennett M, Mattei S, Bovino A, Argentiero L, Magnano A, Devarajan P, Mori K, Erdjument-Bromage H, Tempst P, Allegri L, Barasch J. NGAL (Lcn2) monomer is associated with tubulointerstitial damage in chronic kidney disease. Kidney Int. 2012 Sep; 82(6):718-22. PMID: 22695331.
    Citations: 53     Fields:    Translation:Humans
  102. Verna EC, Brown RS, Farrand E, Pichardo EM, Forster CS, Sola-Del Valle DA, Adkins SH, Sise ME, Oliver JA, Radhakrishnan J, Barasch JM, Nickolas TL. Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis. Dig Dis Sci. 2012 Sep; 57(9):2362-70. PMID: 22562534; PMCID: PMC3979299.
    Citations: 45     Fields:    Translation:Humans
  103. Nickolas TL, Schmidt-Ott KM, Canetta P, Forster C, Singer E, Sise M, Elger A, Maarouf O, Sola-Del Valle DA, O'Rourke M, Sherman E, Lee P, Geara A, Imus P, Guddati A, Polland A, Rahman W, Elitok S, Malik N, Giglio J, El-Sayegh S, Devarajan P, Hebbar S, Saggi SJ, Hahn B, Kettritz R, Luft FC, Barasch J. Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study. J Am Coll Cardiol. 2012 Jan 17; 59(3):246-55. PMID: 22240130; PMCID: PMC3487165.
    Citations: 153     Fields:    Translation:Humans
  104. Sise ME, Forster C, Singer E, Sola-Del Valle D, Hahn B, Schmidt-Ott KM, Barasch J, Nickolas TL. Urine neutrophil gelatinase-associated lipocalin identifies unilateral and bilateral urinary tract obstruction. Nephrol Dial Transplant. 2011 Dec; 26(12):4132-5. PMID: 22049182.
    Citations: 13     Fields:    Translation:Humans
  105. Sola-Del Valle DA, Mohan S, Cheng JT, Paragas NA, Sise ME, D'Agati VD, Barasch J. Urinary NGAL is a useful clinical biomarker of HIV-associated nephropathy. Nephrol Dial Transplant. 2011 Jul; 26(7):2387-90. PMID: 21555394.
    Citations: 12     Fields:    Translation:Humans
  106. Parravicini E, Nemerofsky SL, Michelson KA, Huynh TK, Sise ME, Bateman DA, Lorenz JM, Barasch JM. Urinary neutrophil gelatinase-associated lipocalin is a promising biomarker for late onset culture-positive sepsis in very low birth weight infants. Pediatr Res. 2010 Jun; 67(6):636-40. PMID: 20496473.
    Citations: 25     Fields:    Translation:HumansCells
  107. Huynh TK, Bateman DA, Parravicini E, Lorenz JM, Nemerofsky SL, Sise ME, Bowman TM, Polesana E, Barasch JM. Reference values of urinary neutrophil gelatinase-associated lipocalin in very low birth weight infants. Pediatr Res. 2009 Nov; 66(5):528-32. PMID: 19680166.
    Citations: 26     Fields:    Translation:Humans
  108. Paragas N, Nickolas TL, Wyatt C, Forster CS, Sise M, Morgello S, Jagla B, Buchen C, Stella P, Sanna-Cherchi S, Carnevali ML, Mattei S, Bovino A, Argentiero L, Magnano A, Devarajan P, Schmidt-Ott KM, Allegri L, Klotman P, D'Agati V, Gharavi AG, Barasch J. Urinary NGAL marks cystic disease in HIV-associated nephropathy. J Am Soc Nephrol. 2009 Aug; 20(8):1687-92. PMID: 19628667.
    Citations: 26     Fields:    Translation:HumansAnimals
  109. Sise ME, Barasch J, Devarajan P, Nickolas TL. Elevated urine neutrophil gelatinase-associated lipocalin can diagnose acute kidney injury in patients with chronic kidney diseases. Kidney Int. 2009 Jan; 75(1):115-6; author reply 116. PMID: 19092815.
    Citations: 4     Fields:    Translation:Humans
  110. Nickolas TL, O'Rourke MJ, Yang J, Sise ME, Canetta PA, Barasch N, Buchen C, Khan F, Mori K, Giglio J, Devarajan P, Barasch J. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med. 2008 Jun 03; 148(11):810-9. PMID: 18519927; PMCID: PMC2909852.
    Citations: 254     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Sise's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (275)
Co-Authors (136)
Similar People (60)
Same Department 
Physical Neighbors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.